In summary, the findings successfully delineated the chemical profile and the map of the dynamic biotransformation of PMFs in CRP and effectively narrowed down the range of potential bioactive components in PMFs for the treatment of brain disorders. The gene discussed is CRP; the disease is brain disorder.